Immune Checkpoint Inhibitors May Be Overused at End of Life
With responses to ICIs taking 2 to 3 months, administration of these therapies to patients with poor life expectancies may not be appropriate.
Leah Lawrence
Leah Lawrence is a freelance health writer and editor based in Delaware. She has contributed to trade, consumer, and medical association publications and websites focused on hematology/oncology, cardiology, primary care, endocrinology, and general health.
